Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Hermine O, Dombret H, Poupon J, Arnulf B, Lefrère F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de Thé H, Bazarbachi A.
Hermine O, et al. Among authors: bazarbachi a.
Hematol J. 2004;5(2):130-4. doi: 10.1038/sj.thj.6200374.
Hematol J. 2004.
PMID: 15048063
Clinical Trial.